electroCore (NASDAQ:ECOR) Director Acquires $54,400.00 in Stock

electroCore, Inc. (NASDAQ:ECOR – Get Free Report) Director Thomas Errico bought 10,000 shares of electroCore stock in a transaction on Thursday, November 12th. The shares were purchased at an average cost of $5.44 per share, for a total transaction of $54,400.00. Following the completion of the purchase, the director directly owned 373,904 shares of the company’s stock, valued at $2,034,037.76. This trade represents a 2.75% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link.

electroCore Price Performance

electroCore stock opened at $5.25 on Monday. The firm has a 50 day simple moving average of $9.00 and a 200-day simple moving average of $7.74. The stock has a market cap of $48.46 million, a price-to-earnings ratio of -3.78 and a beta of 1.23. electroCore, Inc. has a 1-year low of $4.37 and a 1-year high of $12.70.

electroCore (NASDAQ:ECOR – Get Free Report) last released its quarterly earnings results on Wednesday, November 4th. The company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.14. The firm had revenue of $9.69 million for the quarter, compared to analysts’ expectations of $10.93 million. Equities analysts expect that electroCore, Inc. will post -1.17 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of electroCore in a report on Monday, September 21st. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, electroCore currently has an average rating of “Hold” and an average price target of $18.00.

View Our Latest Report on ECOR

Hedge Funds Weigh In On electroCore

A hedge fund recently bought a new position in electroCore stock. Cetera Investment Advisers bought a new stake in electroCore, Inc. (NASDAQ:ECOR – Free Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund bought 32,950 shares of the company’s stock, valued at approximately $357,000. Cetera Investment Advisers owned approximately 0.36% of electroCore at the end of the most recent reporting period. Institutional investors own 26.74% of the company’s stock.

About electroCore

(Get Free Report)

electroCore is a medical technology company that develops non-invasive bioelectronic therapies. Its products use non-invasive vagus nerve stimulation (nVNS), which delivers gentle electrical stimulation through the skin to activate the vagus nerve. The company’s gammaCore device is used for the treatment of certain headache conditions, including migraine and cluster headache, subject to its regulatory clearances and indications. electroCore also offers Truvaga, a consumer wellness product that uses non-invasive vagus nerve stimulation.

Read More

Insider Buying and Selling by Quarter for electroCore (NASDAQ:ECOR)

Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.